AlphaYouNK
Insider selling
Neil Kumar sold $1.8M of BridgeBio Pharma, Inc. (BBIO) stock
Neil Kumar, Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO), sold 26,103 shares of BBIO stock worth $1.8M, per an SEC Form 4 filed May 26, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 21, 2026, 5 days before it was made public.
BBIO has moved -5.3% since the trade date, from $70.28 to $66.58 (Sep 21, 2026 close).
- Traded
- May 21, 2026
- Disclosed
- May 26, 2026
- Filing delay
- 5 days
- Price since
- -5.3%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More BBIO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.